About | Free Trial

Last Update

2016-04-28T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong David Hallal?

Mr. David Hallal L.

Chief Executive Officer

Alexion Pharmaceuticals Inc

Direct Phone: (203) ***-****       

Email: d***@***.com

Alexion Pharmaceuticals Inc

352 Knotter Drive

Cheshire, Connecticut 06511

United States

Company Description

Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and delivery of biologic therapeutic products for the treatment disease, including hematologic and neurologic diseases, cancer and autoimmune diso ... more

Find other employees at this company (2,593)

Background Information

Employment History

Director of Sales
Eyetechs Inc

Leadership Positions
Eli Lilly and Company

Education

BA

University of New Hampshire

Web References (199 Total References)


Alexion Reports First Quarter 2016 Results | Business Wire

feeds.businesswire.com, $reference.date [cached]

We are very pleased with the strong start to the Strensiq launches in initial countries and have now commenced the U.S. launch of Kanuma," said David Hallal, Chief Executive Officer of Alexion.


Alexion Reports First Quarter 2016 Results | Business Wire

feeds.businesswire.com, $reference.date [cached]

We are very pleased with the strong start to the Strensiq launches in initial countries and have now commenced the U.S. launch of Kanuma," said David Hallal, Chief Executive Officer of Alexion.


...

www.sec.gov, $reference.date [cached]

0001457477 Hallal David C/O ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510 1 1 0 0 CEO


Dr. Bell is party to a ...

www.sec.gov, $reference.date [cached]

Dr. Bell is party to a consulting agreement with Alexion and Mr. Hallal is party to an employment agreement with Alexion.

...
David Hallal
...
Mr. Hallal became Chief Executive Officer on April 1, 2015. Previously, he was Alexion's Chief Operating Officer since September 2014. From October 2012 to September 2014, Mr. Hallal served as Alexion's Executive Vice President, Chief Commercial Officer. From May 2010 until October 2012, Mr. Hallal was Senior Vice President, Global Commercial Operations and was Senior Vice President, Commercial Operations, Americas from May 2008 until May 2010. Mr. Hallal joined Alexion in June 2006 to build and lead Alexion's U.S. commercial operations, initially with the company's first product launch of Soliris. Prior to joining Alexon in 2006, he had 18 years of commercial operations and leadership experience at a number of companies, including OSI Eyetech, Biogen, Amgen, and Upjohn and he was involved in multiple blockbuster product launches in the areas of hematology, oncology, nephrology and immunology. Mr. Hallal holds a BA in Psychology from the University of New Hampshire.
...
In January 2015, Alexion announced the retirement of Dr. Bell, principal founder of Alexion and its only Chief Executive Officer since its inception in 1992, and the election of Mr. Hallal as the Company's second CEO effective April 1, 2015.
...
Mr. Hallal, an Alexion executive since 2006, has been a


"Synageva is an ideal ...

ihif.net, $reference.date [cached]

"Synageva is an ideal strategic and operational fit for Alexion that aligns with what we know well and do well - providing life-transforming therapies to an increasing number of patients with devastating and rare diseases," said Alexion CEO David Hallal.

Similar Profiles

Other People with this Name (260)

Other people with the name Hallal

Diana Hallal
TMC Financing

Karim Hallal
Canada-Chile Agreement

Alexcia Hallal
Premier Strata Management Pty Ltd

Richard Hallal
Green Tree Frog ABN

Joseph Hallal
Code Three Risk Management Solutions

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory